We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDCW
14076
DELISTED
ProFrac Holding Corp. Warrant
ACDCW
$307 ﹤0.01%
45,161
+13,467
+42% +$257
NEXA icon
14077
Nexa Resources
NEXA
$1.88B
$301 ﹤0.01%
62
-1,100
-95% -$6.24K
REVBW icon
14078
Revelation Biosciences Warrant
REVBW
$9.12K
$294 ﹤0.01%
14,720
-2,419
-14% -$44
SWVLW icon
14079
Swvl Holdings Corp Warrant
SWVLW
$292 ﹤0.01%
17,459
+2,772
+19% +$50
PHXM
14080
CALL
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$292 ﹤0.01%
40
MIST icon
14081
CALL
Milestone Pharmaceuticals
MIST
$136M
$285 ﹤0.01%
100
-5,600
-98% -$21.1K
SCM icon
14082
Stellus Capital Investment Corp
SCM
$248M
$281 ﹤0.01%
20
-17,190
-100% -$244K
CPSH icon
14083
PUT
CPS Technologies
CPSH
$83.9M
$280 ﹤0.01%
100
-1,500
-94% -$4.33K
ACAHW
14084
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$267 ﹤0.01%
+11,799
New +$591
TRKAW
14085
DELISTED
Troika Media Group, Inc. Warrant
TRKAW
$266 ﹤0.01%
13,993
+448
+3% +$20
OXSQ icon
14086
PUT
Oxford Square Capital
OXSQ
$157M
$265 ﹤0.01%
100
AUR icon
14087
Aurora
AUR
$13.9B
$259 ﹤0.01%
88
-1,041,597
-100% -$1.74M
CORS.WS
14088
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$253 ﹤0.01%
+31,282
New +$5.39K
MRSN
14089
DELISTED
Mersana Therapeutics
MRSN
$250 ﹤0.01%
3
-4,503
-100% -$659K
CRIS icon
14090
PUT
Curis
CRIS
$3.85M
$249 ﹤0.01%
1
YI
14091
CALL
111 Inc
YI
$33.4M
$246 ﹤0.01%
+10
New +$268
YI
14092
PUT
111 Inc
YI
$33.4M
$246 ﹤0.01%
10
TKAT
14093
CALL
DELISTED
Takung Art Co., Ltd.
TKAT
$245 ﹤0.01%
700
-1,600
-70% -$828
OPAD.WS
14094
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$243 ﹤0.01%
+12,040
New +$287
VRM icon
14095
Vroom Inc
VRM
$56.8M
$242 ﹤0.01%
+2
New +$152
VANI icon
14096
PUT
Vivani Medical
VANI
$121M
$240 ﹤0.01%
+198
New +$244
HYPD
14097
CALL
Hyperion DeFi Inc
HYPD
$41.2M
$237 ﹤0.01%
+1
New +$287
LMND.WS
14098
DELISTED
Lemonade Inc Warrants
LMND.WS
$235 ﹤0.01%
+11,817
New +$310
SWSSW
14099
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$234 ﹤0.01%
10,790
+543
+5% +$16
PEPLW
14100
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$233 ﹤0.01%
11,511
+1,053
+10% +$57

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.